Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition
暂无分享,去创建一个
A. Das | V. De Feo | M. Zia-ul-Haq | M. Riaz | S. Dewanjee | M. Gangopadhyay | Niloy Bhattacharjee | R. Khanra | Swarnalata Joardar | Tarun K Dua | M. Zia‐ul‐Haq
[1] A. Hofmann,et al. Dihydro‐β‐agarofurans from the Australian Endemic Rainforest Plant Denhamia pittosporoides Inhibit Leucine Transport in Prostate Cancer Cells , 2016 .
[2] Hui Sun,et al. Rhamnetin induces sensitization of hepatocellular carcinoma cells to a small molecular kinase inhibitor or chemotherapeutic agents. , 2016, Biochimica et biophysica acta.
[3] Wei Wei,et al. Advances in plant-based inhibitors of P-glycoprotein , 2016, Journal of enzyme inhibition and medicinal chemistry.
[4] N. Yellu,et al. Effect of resveratrol on the pharmacokinetics of fexofenadine in rats: Involvement of P-glycoprotein inhibition , 2016, Pharmacological reports : PR.
[5] A. Bello,et al. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection , 2016, Antiviral Research.
[6] Yuefei Wang,et al. Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model , 2015, International journal of molecular sciences.
[7] S. Misaka,et al. Inhibitory Effects of Green Tea and (–)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein , 2015, PloS one.
[8] J. Behravan,et al. Reversal of P-glycoprotein-mediated multidrug resistance in MCF-7/Adr cancer cells by sesquiterpene coumarins. , 2015, Fitoterapia.
[9] Maria-José U. Ferreira,et al. Enhancing activity of antibiotics against Staphylococcus aureus: Zanthoxylum capense constituents and derivatives. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[10] Sergio Martínez-Luis,et al. Marine Natural Products as Breast Cancer Resistance Protein Inhibitors , 2015, Marine drugs.
[11] T. Kawasaki,et al. Effects of natural nuclear factor-kappa B inhibitors on anticancer drug efflux transporter human P-glycoprotein. , 2015, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[12] T. Efferth,et al. Cytotoxicity of the indole alkaloid reserpine from Rauwolfia serpentina against drug-resistant tumor cells. , 2015, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[13] Sung-Wuk Jang,et al. Glaucine inhibits breast cancer cell migration and invasion by inhibiting MMP-9 gene expression through the suppression of NF-κB activation , 2015, Molecular and Cellular Biochemistry.
[14] K. Rameshkumar,et al. Curcuma ecalcarata – new natural source of pinocembrin and piperitenone , 2015, Natural product research.
[15] P. Babu,et al. Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro , 2014, Drug development and industrial pharmacy.
[16] L. Walker,et al. Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents , 2014, Front. Pharmacol..
[17] M. Wink,et al. Tetrandrine and fangchinoline, bisbenzylisoquinoline alkaloids from Stephania tetrandra can reverse multidrug resistance by inhibiting P-glycoprotein activity in multidrug resistant human cancer cells. , 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[18] B. Li,et al. In Vitro Inhibitory Effects of Scutellarin on Six Human/Rat Cytochrome P450 Enzymes and P-glycoprotein , 2014, Molecules.
[19] Zhihao Liu,et al. Inhibitory effects of herbal constituents on P-glycoprotein in vitro and in vivo: herb-drug interactions mediated via P-gp. , 2014, Toxicology and applied pharmacology.
[20] A. Wallqvist,et al. Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication. , 2014, Bioorganic & medicinal chemistry.
[21] F. Lévi,et al. Optimization of irinotecan chronotherapy with P-glycoprotein inhibition. , 2014, Toxicology and applied pharmacology.
[22] Sergio Martínez-Luis,et al. Marine Natural Products with P-Glycoprotein Inhibitor Properties , 2014, Marine drugs.
[23] N. S. Yarla,et al. Bioactive Flavonoids as ABC Transporters Inhibitors for Reversion of Multidrug Resistance in Cancer , 2013 .
[24] M. Wink,et al. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[25] Jin Si,et al. Icaritin reverses multidrug resistance of HepG2/ADR human hepatoma cells via downregulation of MDR1 and P‑glycoprotein expression. , 2013, Molecular medicine reports.
[26] A. Shafiee,et al. Biological Activities and Pharmacokinetics of Praeruptorins from Peucedanum Species: A Systematic Review , 2013, BioMed research international.
[27] O. Erez,et al. Cannabidiol changes P-gp and BCRP expression in trophoblast cell lines , 2013, PeerJ.
[28] Shengyao Wang,et al. Grape Seed Procyanidin Reversal of P-glycoprotein Associated Multi-Drug Resistance via Down-regulation of NF-κB and MAPK/ERK Mediated YB-1 Activity in A2780/T Cells , 2013, PloS one.
[29] Jianping Chen,et al. Natural Borneol, a Monoterpenoid Compound, Potentiates Selenocystine-Induced Apoptosis in Human Hepatocellular Carcinoma Cells by Enhancement of Cellular Uptake and Activation of ROS-Mediated DNA Damage , 2013, PloS one.
[30] S. Srivastava,et al. Antibacterial and Synergy of Clavine Alkaloid Lysergol and its Derivatives Against Nalidixic Acid‐Resistant Escherichia coli , 2013, Chemical biology & drug design.
[31] Michael R Hamblin,et al. Send Orders of Reprints at Reprints@benthamscience.net Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation , 2022 .
[32] Z. Binkhathlan,et al. P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives. , 2013, Current cancer drug targets.
[33] M. Wink,et al. An isoquinoline alkaloid from the Chinese herbal plant Corydalis yanhusuo W.T. Wang inhibits P-glycoprotein and multidrug resistance-associate protein 1. , 2013, Food chemistry.
[34] Ricardo J. Ferreira,et al. Enhancing macrocyclic diterpenes as multidrug-resistance reversers: structure-activity studies on jolkinol D derivatives. , 2013, Journal of medicinal chemistry.
[35] Ming Yan,et al. Gambogic Acid as a Non‐Competitive Inhibitor of ATP‐Binding Cassette Transporter B1 Reverses the Multidrug Resistance of Human Epithelial Cancers by Promoting ATP‐Binding Cassette Transporter B1 Protein Degradation , 2013, Basic & clinical pharmacology & toxicology.
[36] Quan Xia,et al. Reversal of P‐glycoprotein‐mediated multidrug resistance of human hepatic cancer cells by Astragaloside II , 2012, The Journal of pharmacy and pharmacology.
[37] R. Gambari,et al. Phytochemical Analysis and Cytotoxicity Towards Multidrug-Resistant Leukemia Cells of Essential Oils Derived from Lebanese Medicinal Plants , 2012, Planta Medica.
[38] Maria-José U. Ferreira,et al. Jatrophane diterpenes from Euphorbia mellifera and their activity as P-glycoprotein modulators on multidrug-resistant mouse lymphoma and human colon adenocarcinoma cells. , 2012, Journal of natural products.
[39] P. Lakshmi,et al. Overview of P-glycoprotein inhibitors: a rational outlook , 2012 .
[40] M. Wink,et al. Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents , 2012, Front. Microbio..
[41] Eunhye Kim,et al. Anti-proliferative activity and suppression of P-glycoprotein by (-)-antofine, a natural phenanthroindolizidine alkaloid, in paclitaxel-resistant human lung cancer cells. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[42] G. Du,et al. Uptake characteristics of pinocembrin and its effect on p-glycoprotein at the blood–brain barrier in in vitro cell experiments , 2012, Journal of Asian natural products research.
[43] Minhee Kim,et al. Effects of baicalein on the pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats: Possible role of cytochrome p450 3A4 and P-glycoprotein inhibition by baicalein , 2011, Archives of pharmacal research.
[44] Yong-long Han,et al. Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro. , 2011, Toxicology in vitro : an international journal published in association with BIBRA.
[45] K. Kwon,et al. Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats , 2011, Xenobiotica; the fate of foreign compounds in biological systems.
[46] Soo-Jin Jeong,et al. Hydrocinchonine, cinchonine, and quinidine potentiate paclitaxel‐induced cytotoxicity and apoptosis via multidrug resistance reversal in MES‐SA/DX5 uterine sarcoma cells , 2011, Environmental toxicology.
[47] N. Tinari,et al. Strain- and Sex-Dependent Circadian Changes in Abcc2 Transporter Expression: Implications for Irinotecan Chronotolerance in Mouse Ileum , 2011, PloS one.
[48] J. Molnár,et al. Alkaloids derived from genus Veratrum and Peganum of Mongolian origin as multidrug resistance inhibitors of cancer cells. , 2011, Fitoterapia.
[49] Y. Kashiwada,et al. New 29-nor-cycloartanes with a 3,4-seco- and a novel 2,3-seco-structure from the leaves of Sinocalycanthus chinensis. , 2011, Bioorganic & medicinal chemistry.
[50] Chie Suzuki,et al. Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects , 2011, Cancer Chemotherapy and Pharmacology.
[51] Andrew M. Piggott,et al. Nocardioazines: a novel bridged diketopiperazine scaffold from a marine-derived bacterium inhibits P-glycoprotein. , 2011, Organic letters.
[52] J. Behravan,et al. Farnesiferol A from Ferula persica and galbanic acid from Ferula szowitsiana inhibit P-glycoprotein-mediated rhodamine efflux in breast cancer cell lines. , 2011, Planta medica.
[53] Michael R Hamblin,et al. Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria , 2011, PloS one.
[54] Sang-Chul Shin,et al. Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in Rats: Possible role of CYP3A4 and P-glycoprotein inhibition by myricetin , 2011, Archives of pharmacal research.
[55] M. Morris,et al. 5,7-Dimethoxyflavone and Multiple Flavonoids in Combination Alter the ABCG2-Mediated Tissue Distribution of Mitoxantrone in Mice , 2011, Pharmaceutical Research.
[56] H. Greger,et al. Stemona alkaloids, from traditional Thai medicine, increase chemosensitivity via P-glycoprotein-mediated multidrug resistance. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[57] S. Ignacimuthu,et al. Antimycobacterial activity of two natural alkaloids, vasicine acetate and 2-acetyl benzylamine, isolated from Indian shrub Adhatoda vasica Ness. leaves , 2010, Journal of Biosciences.
[58] D. Duś,et al. 8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1. , 2010, European journal of pharmacology.
[59] Nicolas Tournier,et al. Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). , 2010, The international journal of neuropsychopharmacology.
[60] M. Kumar,et al. Piperine as an inhibitor of Rv1258c, a putative multidrug efflux pump of Mycobacterium tuberculosis. , 2010, The Journal of antimicrobial chemotherapy.
[61] M. Iranshahi,et al. Effect Of Galbanic Acid, A Sesquiterpene Coumarin From Ferula Szowitsiana, As An Inhibitor Of Efflux Mechanism In Resistant Clinical Isolates Of Staphylococcus Aureus , 2010, Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology].
[62] M. Rybczyńska,et al. Phytosterols in physiological concentrations target multidrug resistant cancer cells. , 2010, Medicinal chemistry (Shariqah (United Arab Emirates)).
[63] M. M. Rahman,et al. Natural and synthetic compounds such as trimethoprim behave as inhibitors of efflux in Gram-negative bacteria. , 2010, The Journal of antimicrobial chemotherapy.
[64] J. Pagés,et al. Efflux Pumps Are Involved in the Defense of Gram-Negative Bacteria against the Natural Products Isobavachalcone and Diospyrone , 2010, Antimicrobial Agents and Chemotherapy.
[65] S. Sharma,et al. Modulation of P‐glycoprotein ATPase activity by some phytoconstituents , 2010, Phytotherapy research : PTR.
[66] S. Yamada,et al. Effects of dietary ingredients on function and expression of P-glycoprotein in human intestinal epithelial cells. , 2010, Biological & pharmaceutical bulletin.
[67] M. Wink,et al. Inhibition of P-glycoprotein activity by limonin and other secondary metabolites from Citrus species in human colon and leukaemia cell lines. , 2010, European journal of pharmacology.
[68] M. Wink,et al. The beta‐carboline alkaloid harmine inhibits BCRP and can reverse resistance to the anticancer drugs mitoxantrone and camptothecin in breast cancer cells , 2010, Phytotherapy research : PTR.
[69] S. Castanys,et al. Novel dihydro-beta-agarofuran sesquiterpenes as potent modulators of human P-glycoprotein dependent multidrug resistance. , 2009, Organic & biomolecular chemistry.
[70] M. F. Souza,et al. Modulation of drug resistance in staphylococcus aureus by a kaempferol glycoside from herissantia tiubae (malvaceae) , 2009, Phytotherapy research : PTR.
[71] Maria-José U. Ferreira,et al. New potent P-glycoprotein modulators with the cucurbitane scaffold and their synergistic interaction with doxorubicin on resistant cancer cells. , 2009, Bioorganic & medicinal chemistry.
[72] R. Bauer,et al. Inhibition of P-glycoprotein at the blood-brain barrier by phytochemicals derived from traditional Chinese medicine. , 2009, Cancer genomics & proteomics.
[73] Ming Yan,et al. Inhibition of P‐glycoprotein function by procyanidine on blood–brain barrier , 2009, Phytotherapy research : PTR.
[74] Zhe-Sheng Chen,et al. Sipholane triterpenoids: chemistry, reversal of ABCB1/P-glycoprotein-mediated multidrug resistance, and pharmacophore modeling. , 2009, Journal of natural products.
[75] A. Ali,et al. Inhibitory and Resistance-Modifying Potential of Plant-Based Alkaloids Against Methicillin-Resistant Staphylococcus aureus (MRSA) , 2009, Current Microbiology.
[76] Sushama Talegaonkar,et al. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[77] Ho-jin Jung,et al. Potent modulation of P‐glycoprotein activity by naturally occurring phenylbutenoids from Zingiber cassumunar , 2009, Phytotherapy research : PTR.
[78] A. di Pietro,et al. Jatrophane diterpenes from Euphorbia spp. as modulators of multidrug resistance in cancer therapy , 2009, Phytochemistry Reviews.
[79] Jiantao Ye,et al. [Reversal effect and its mechanism of ampelopsin on multidrug resistance in K562/ADR cells]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[80] J. Molnár,et al. Perturbation of the lipid phase of a membrane is not involved in the modulation of MRP1 transport activity by flavonoids , 2008, Cellular & Molecular Biology Letters.
[81] G. Kruh,et al. The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms. , 2008, Cancer research.
[82] Xuehua Jiang,et al. Intra-herb pharmacokinetics interaction between quercetin and isorhamentin , 2008, Acta Pharmacologica Sinica.
[83] Q. Ma,et al. Reversal effect of resveratrol on multidrug resistance in KBv200 cell line. , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[84] Maria-José U. Ferreira,et al. Synergistic interaction between p-glycoprotein modulators and epirubicine on resistant cancer cells. , 2008, Bioorganic & medicinal chemistry.
[85] M. VanNieuwenhze,et al. A new total synthesis of patellamide A. , 2008, Organic letters.
[86] M. Wink,et al. Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[87] J. Molnár,et al. Antitumour properties of acridone alkaloids on a murine lymphoma cell line. , 2008, Anticancer research.
[88] L. Lim,et al. In vitro and in vivo evaluation of the effects of piperine on P-gp function and expression. , 2008, Toxicology and applied pharmacology.
[89] S. Gibbons,et al. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. , 2008, The Journal of antimicrobial chemotherapy.
[90] Ying-Jie Hu,et al. Tenacigenin B derivatives reverse P-glycoprotein-mediated multidrug resistance inHepG2/Dox cells. , 2008, Journal of natural products.
[91] S. Mertens-Talcott,et al. Effect of grapefruit juice, naringin, naringenin, and bergamottin on the intestinal carrier-mediated transport of talinolol in rats. , 2008, Journal of agricultural and food chemistry.
[92] H. Lou,et al. Plagiochin E, a botanic‐derived phenolic compound, reverses fungal resistance to fluconazole relating to the efflux pump , 2008, Journal of applied microbiology.
[93] Gleice da Graça Rocha,et al. Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines. , 2007, Bioorganic & medicinal chemistry.
[94] S. Mertens-Talcott,et al. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells. , 2007, Journal of pharmaceutical sciences.
[95] S. Gibbons. Phytochemicals for Bacterial Resistance - Strengths, Weaknesses and Opportunities , 2007, Planta medica.
[96] Shufeng Zhou,et al. Identification of drugs that interact with herbs in drug development. , 2007, Drug discovery today.
[97] Simon Gibbons,et al. The Phenolic Diterpene Totarol Inhibits Multidrug Efflux Pump Activity in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.
[98] S. Gibbons,et al. Antibacterial activity of two canthin‐6‐one alkaloids from Allium neapolitanum , 2007, Phytotherapy research : PTR.
[99] L. Piddock,et al. Bacterial efflux pump inhibitors from natural sources. , 2007, The Journal of antimicrobial chemotherapy.
[100] S. Bates,et al. Inhibition of ABCG2-mediated transport by protein kinase inhibitors with a bisindolylmaleimide or indolocarbazole structure , 2007, Molecular Cancer Therapeutics.
[101] J. Schellens,et al. A Phase I, Randomized, Open-Label, Parallel-Cohort, Dose-Finding Study of Elacridar (GF120918) and Oral Topotecan in Cancer Patients , 2007, Clinical Cancer Research.
[102] S. Akiyama,et al. Reversal of P-glycoprotein-mediated multidrug resistance by sipholane triterpenoids. , 2007, Journal of natural products.
[103] G. Kaatz,et al. N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. , 2007, Bioorganic & medicinal chemistry letters.
[104] S. Mertens-Talcott,et al. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. , 2007, Journal of agricultural and food chemistry.
[105] K. Linton,et al. Structure and function of ABC transporters: the ATP switch provides flexible control , 2007, Pflügers Archiv - European Journal of Physiology.
[106] D. Jang,et al. P‐Glycoprotein Inhibitory Activity of Two Phenolic Compounds, (−)‐Syringaresinol and Tricin from Sasa borealis , 2007, Chemistry & biodiversity.
[107] Naoko Yoshida,et al. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. , 2006, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[108] R. Bendayan,et al. In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[109] Chi-Keung Wan,et al. Gomisin A alters substrate interaction and reverses P-glycoprotein-mediated multidrug resistance in HepG2-DR cells. , 2006, Biochemical pharmacology.
[110] Sang-Un Choi,et al. Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome ofCoptis japonica Makino , 2006, Archives of pharmacal research.
[111] B. Trump,et al. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[112] Sang-Un Choi,et al. Aporphine alkaloids and their reversal activity of multidrug resistance (MDR) from the stems and rhizomes ofSinomenium acutum , 2006, Archives of pharmacal research.
[113] R. Béliveau,et al. Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. , 2006, Planta medica.
[114] Maria-José U. Ferreira,et al. Euphoportlandols A and B, tetracylic diterpene polyesters from Euphorbia portlandica and their anti-MDR effects in cancer cells. , 2006, Journal of natural products.
[115] J. Donovan,et al. Characterization of P-glycoprotein Inhibition by Major Cannabinoids from Marijuana , 2006, Journal of Pharmacology and Experimental Therapeutics.
[116] A. S. Lynch. Efflux systems in bacterial pathogens: an opportunity for therapeutic intervention? An industry view. , 2006, Biochemical pharmacology.
[117] K. Bostian,et al. Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use. , 2006, Biochemical pharmacology.
[118] M. Chavez,et al. Evidence-based drug--herbal interactions. , 2006, Life sciences.
[119] J. Aponte,et al. Aegicerin, the first oleanane triterpene with wide-ranging antimycobacterial activity, isolated from Clavija procera. , 2006, Journal of natural products.
[120] G. Kaatz,et al. Polyacylated oligosaccharides from medicinal Mexican morning glory species as antibacterials and inhibitors of multidrug resistance in Staphylococcus aureus. , 2006, Journal of natural products.
[121] G. Tegos,et al. Metabolites of the "smoke tree", Dalea spinosa, potentiate antibiotic activity against multidrug-resistant Staphylococcus aureus. , 2006, Journal of natural products.
[122] Naoko Yoshida,et al. Inhibition of P-glycoprotein-mediated transport by extracts of and monoterpenoids contained in Zanthoxyli fructus. , 2005, Toxicology and applied pharmacology.
[123] A. Calcabrini,et al. Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells. , 2005, International journal of oncology.
[124] K. Miyamoto,et al. Reversal of P-glycoprotein-dependent resistance to vinblastine by newly synthesized bisbenzylisoquinoline alkaloids in mouse leukemia P388 cells. , 2005, Biological & pharmaceutical bulletin.
[125] Maria-José U. Ferreira,et al. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by diterpenic lactones. , 2005, Anticancer research.
[126] Roman Rouzier,et al. Phase II study of tariquidar, a selective P‐glycoprotein inhibitor, in patients with chemotherapy‐resistant, advanced breast carcinoma , 2005, Cancer.
[127] J. Pagés,et al. Inhibitors of efflux pumps in Gram-negative bacteria. , 2005, Trends in molecular medicine.
[128] D. Clarke,et al. Recent Progress in Understanding the Mechanism of P-Glycoprotein-mediated Drug Efflux , 2005, The Journal of Membrane Biology.
[129] P. van Bladeren,et al. Inhibition of multidrug resistance proteins MRP1 and MRP2 by a series of alpha,beta-unsaturated carbonyl compounds. , 2005, Biochemical pharmacology.
[130] H. Okumura,et al. Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells , 2005, Cancer science.
[131] S. Wolffram,et al. Modulation of drug transport by selected flavonoids: Involvement of P-gp and OCT? , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[132] E. Williamson,et al. Isopimaric acid from Pinus nigra shows activity against multidrug‐resistant and EMRSA strains of Staphylococcus aureus , 2005, Phytotherapy research : PTR.
[133] R. Béliveau,et al. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin , 2005, Cancer Chemotherapy and Pharmacology.
[134] D. Clarke,et al. Do drug substrates enter the common drug-binding pocket of P-glycoprotein through "gates"? , 2005, Biochemical and biophysical research communications.
[135] J. Molnár,et al. In vitro search for synergy between flavonoids and epirubicin on multidrug-resistant cancer cells. , 2005, In vivo.
[136] S. Kitagawa,et al. Effects of dietary chemopreventive phytochemicals on P-glycoprotein function. , 2005, Biochemical and biophysical research communications.
[137] R. Ho,et al. Characterization of the humanMDR1 gene , 2005, The AAPS Journal.
[138] Mustafa Usta,et al. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2. , 2005, Biochemical pharmacology.
[139] D. Cohen,et al. Efflux transporters and their clinical relevance. , 2005, Mini reviews in medicinal chemistry.
[140] D. Clarke,et al. The Dileucine Motif at the COOH Terminus of Human Multidrug Resistance P-glycoprotein Is Important for Folding but Not Activity* , 2005, Journal of Biological Chemistry.
[141] E. Chieli,et al. Effects of grapefruit juice on the multidrug transporter P-glycoprotein in the human proximal tubular cell line HK-2. , 2004, Life sciences.
[142] I. Muhammad,et al. Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide , 2004, Phytotherapy research : PTR.
[143] G. Cook,et al. Acquired Bacitracin Resistance in Enterococcus faecalis Is Mediated by an ABC Transporter and a Novel Regulatory Protein, BcrR , 2004, Antimicrobial Agents and Chemotherapy.
[144] M. Hayashi,et al. Cytotoxic effects and reversal of multidrug resistance by ibogan and related indole alkaloids. , 2004, Bioorganic & medicinal chemistry letters.
[145] S. Akiyama,et al. Kendarimide A, a novel peptide reversing P-glycoprotein-mediated multidrug resistance in tumor cells, from a marine sponge of Haliclona sp. , 2004 .
[146] Y. Sugimoto,et al. Phytoestrogens/Flavonoids Reverse Breast Cancer Resistance Protein/ABCG2-Mediated Multidrug Resistance , 2004, Cancer Research.
[147] M. Morris,et al. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport. , 2004, Molecular pharmacology.
[148] D. Clarke,et al. Val133 and Cys137 in Transmembrane Segment 2 Are Close to Arg935 and Gly939 in Transmembrane Segment 11 of Human P-glycoprotein* , 2004, Journal of Biological Chemistry.
[149] S. Hladky,et al. Interaction of the breast cancer resistance protein with plant polyphenols. , 2004, Biochemical and biophysical research communications.
[150] P. Limtrakul,et al. Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids , 2004, BMC Cancer.
[151] D. Clarke,et al. Disulfide Cross-linking Analysis Shows That Transmembrane Segments 5 and 8 of Human P-glycoprotein Are Close Together on the Cytoplasmic Side of the Membrane* , 2004, Journal of Biological Chemistry.
[152] A. E. Senior,et al. Synergy between Conserved ABC Signature Ser Residues in P-glycoprotein Catalysis* , 2004, Journal of Biological Chemistry.
[153] L. Pardo,et al. SAR studies of dihydro-beta-agarofuran sesquiterpenes as inhibitors of the multidrug-resistance phenotype in a Leishmania tropica line overexpressing a P-glycoprotein-like transporter. , 2004, Journal of medicinal chemistry.
[154] A. Calcabrini,et al. Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells. , 2003, International journal of oncology.
[155] G. Chang. Multidrug resistance ABC transporters , 2003, FEBS letters.
[156] C. Dey,et al. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. , 2003, Pharmacological research.
[157] C. Porter,et al. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[158] H. Lage. ABC-transporters: implications on drug resistance from microorganisms to human cancers. , 2003, International journal of antimicrobial agents.
[159] A. Speciale,et al. Berberis aetnensis C. Presl. extracts: antimicrobial properties and interaction with ciprofloxacin. , 2003, International journal of antimicrobial agents.
[160] Willem Boogerd,et al. Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[161] G. Tegos,et al. Polyacylated neohesperidosides from Geranium caespitosum: bacterial multidrug resistance pump inhibitors. , 2003, Bioorganic & medicinal chemistry letters.
[162] D. Boger,et al. Multidrug resistance reversal activity of key ningalin analogues. , 2003, Bioorganic & medicinal chemistry letters.
[163] M. Ratain,et al. Irinotecan treatment in cancer patients with UGT1A1 polymorphisms. , 2003, Oncology.
[164] Shuzhong Zhang,et al. Effects of the Flavonoids Biochanin A, Morin, Phloretin, and Silymarin on P-Glycoprotein-Mediated Transport , 2003, Journal of Pharmacology and Experimental Therapeutics.
[165] P. Tulkens,et al. Influence of P-Glycoprotein Inhibitors on Accumulation of Macrolides in J774 Murine Macrophages , 2003, Antimicrobial Agents and Chemotherapy.
[166] S. Gibbons,et al. Activity of Zanthoxylum clava‐herculis extracts against multi‐drug resistant methicillin‐resistant Staphylococcus aureus (mdr‐MRSA) , 2003, Phytotherapy research : PTR.
[167] C. Choi,et al. Reversal of P-Glycoprotein-Mediated Multidrug Resistance by Protopanaxatriol Ginsenosides from Korean Red Ginseng , 2003, Planta medica.
[168] C. Gattass,et al. Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. , 2003, Cancer letters.
[169] P. Augustijns,et al. The effect of food components on the absorption of P‐gp substrates: a review , 2003, The Journal of pharmacy and pharmacology.
[170] M. Morris,et al. Effect of flavonoids on MRP1-mediated transport in Panc-1 cells. , 2003, Journal of Pharmacy and Science.
[171] G. Tegos,et al. Two flavonols from Artemisa annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. , 2002, Planta medica.
[172] Y. Pommier,et al. Overcoming multidrug drug resistance in P-glycoprotein/MDR1-overexpressing cell lines by ecteinascidin 743. , 2002, Molecular cancer therapeutics.
[173] R. Agarwal,et al. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis. , 2002, Clinical Cancer Research.
[174] E. Schuetz,et al. Interaction of Cytochrome P450 3A Inhibitors with P-Glycoprotein , 2002, Journal of Pharmacology and Experimental Therapeutics.
[175] K. Hahm,et al. Reversal of P-glycoprotein-mediated multidrug resistance by 5,6,7,3',4'-pentamethoxyflavone (Sinensetin). , 2002, Biochemical and biophysical research communications.
[176] Ling He,et al. Effects of various principles from Chinese herbal medicine on rhodamine123 accumulation in brain capillary endothelial cells. , 2002, Acta pharmacologica Sinica.
[177] Z. Ding,et al. The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death. , 2002, Biochemical pharmacology.
[178] R. Béliveau,et al. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. , 2002, Biochimica et biophysica acta.
[179] V. Skulachev,et al. Transfer of Cationic Antibacterial Agents Berberine, Palmatine, and Benzalkonium Through Bimolecular Planar Phospholipid Film and Staphylococcus aureus Membrane , 2001, IUBMB life.
[180] M. Kuroda,et al. The emergence and evolution of methicillin-resistant Staphylococcus aureus. , 2001, Trends in microbiology.
[181] J. Pezzuto,et al. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype. , 2001, Cancer research.
[182] K. Gallicano,et al. An in vitro evaluation of human cytochrome P450 3A4 and P-glycoprotein inhibition by garlic. , 2001, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[183] C. Higgins,et al. ABC transporters: physiology, structure and mechanism--an overview. , 2001, Research in microbiology.
[184] M. Liscovitch,et al. Inhibitory effect of steroidal alkaloids on drug transport and multidrug resistance in human cancer cells. , 2001, Anticancer research.
[185] B. Chauffert,et al. Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes , 2000, Leukemia.
[186] T. Tsuruo,et al. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. , 2000, Cancer letters.
[187] L. Mayer,et al. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[188] G. Szakács,et al. MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping* , 2000, The Journal of Biological Chemistry.
[189] Y. Sawada,et al. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco‐2 cells and on the activity of cytochrome P450 3A4 , 2000, British journal of pharmacology.
[190] I. Pastan,et al. Analysis of the properties of the N-terminal nucleotide-binding domain of human P-glycoprotein. , 2000, Biochemistry.
[191] T. Tsuruo,et al. Effect of bioflavonoids on vincristine transport across blood-brain barrier. , 2000, European journal of pharmacology.
[192] S. Gibbons,et al. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant , 2000, Phytotherapy research : PTR.
[193] D. Back,et al. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. , 1999, British journal of clinical pharmacology.
[194] M. Hayashi,et al. Reversal of multidrug resistance by kopsiflorine isolated from Kopsia dasyrachis. , 1999, Planta medica.
[195] Li-Wei Hung,et al. Crystal structure of the ATP-binding subunit of an ABC transporter , 1998, Nature.
[196] M. Grant,et al. The effect of the flavonoids, quercetin, myricetin and epicatechin on the growth and enzyme activities of MCF7 human breast cancer cells. , 1998, Chemico-biological interactions.
[197] F. Schmitz,et al. New cyclic peptides from the ascidian Lissoclinum patella. , 1998, Journal of natural products.
[198] M. Hayashi,et al. Reversal of multidrug resistance (MDR) by aspidofractinine-type indole alkaloids. , 1998, Bioorganic & medicinal chemistry letters.
[199] H. Grunicke,et al. PKC-independent modulation of multidrug resistance in cells with mutant (V185) but not wild-type (G185) P-glycoprotein by bryostatin 1. , 1998, Biochemical pharmacology.
[200] I. Pastan,et al. Structural flexibility of the linker region of human P-glycoprotein permits ATP hydrolysis and drug transport. , 1998, Biochemistry.
[201] S. Akiyama,et al. Agosterol A, a Novel Polyhydroxylated Sterol Acetate Reversing Multidrug Resistance from a Marine Sponge of Spongia sp. , 1998 .
[202] W. Bornmann,et al. Reversal of anticancer multidrug resistance by the ardeemins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[203] Sang-Un Choi,et al. The bis benzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance‐related drugs via modulation of P‐glycoprotein , 1998, Anti-cancer drugs.
[204] I. Paulsen,et al. Major Facilitator Superfamily , 1998, Microbiology and Molecular Biology Reviews.
[205] P. Giannakakou,et al. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells. , 1997, Molecular pharmacology.
[206] K. Kohn,et al. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[207] H. Tian,et al. Modulation of multidrug resistance by three bisbenzyl-isoquinolines in comparison with verapamil. , 1997, Zhongguo yao li xue bao = Acta pharmacologica Sinica.
[208] K. Ueda,et al. How does P-glycoprotein recognize its substrates? , 1997, Seminars in cancer biology.
[209] Piet Borst,et al. MDR1 P-Glycoprotein Is a Lipid Translocase of Broad Specificity, While MDR3 P-Glycoprotein Specifically Translocates Phosphatidylcholine , 1996, Cell.
[210] A. Quesada,et al. Polyaromatic alkaloids from marine invertebrates as cytotoxic compounds and inhibitors of multidrug resistance caused by P-glycoprotein. , 1996, British Journal of Cancer.
[211] J. Samuelson,et al. Increase in mRNA of multiple Eh pgp genes encoding P-glycoprotein homologues in emetine-resistant Entamoeba histolytica parasites. , 1995, Gene.
[212] C. Jacquelinet,et al. Multi-drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay. , 1995, Leukemia.
[213] T. Tsuruo,et al. Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro. , 1995, Biochemical pharmacology.
[214] Richard E. Moore,et al. Hapalosin, a Cyanobacterial Cyclic Depsipeptide with Multidrug- Resistance Reversing Activity. , 1995 .
[215] J. T. Zilfou,et al. Welwitindolinone analogues that reverse P-glycoprotein-mediated multiple drug resistance. , 1995, Molecular pharmacology.
[216] G. Cordell,et al. Indole alkaloids from Peschiera laeta that enhance vinblastine-mediated cytotoxicity with multidrug-resistant cells. , 1994, Journal of natural products.
[217] T. Tsuruo,et al. Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52. , 1994, Biochemical pharmacology.
[218] G. C. Yeh,et al. Modulation of adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells. Activation of P-glycoprotein as a putative mechanism. , 1994, Biochemical pharmacology.
[219] M. Ouellette,et al. P-glycoprotein overexpression in methotrexate-resistant Leishmania tropica. , 1994, Biochemical pharmacology.
[220] G. C. Yeh,et al. Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. , 1993, Cancer research.
[221] O. Fardel,et al. Detection of P glycoprotein activity on normal and leukemic CD34+ cells. , 1993, Leukemia research.
[222] R. Jacobs,et al. A marine natural product, patellamide D, reverses multidrug resistance in a human leukemic cell line. , 1993, Cancer letters.
[223] R. Arceci,et al. Constitutive expression of multidrug resistance in human colorectal tumours and cell lines. , 1993, British Journal of Cancer.
[224] J. Phillipson,et al. Antimalarial activity of Artemisia annua flavonoids from whole plants and cell cultures , 1992, Plant Cell Reports.
[225] I. Roninson,et al. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.
[226] H. Garewal,et al. Expression of the multidrug resistance gene product (P‐glycoprotein) in myelodysplasia is associated with a stem cell phenotype , 1991, British journal of haematology.
[227] Frank Koehn,et al. Antitumor tetrahydroisoquinoline alkaloids from the colonial ascidian Ecteinascidia turbinata , 1990 .
[228] J. Bourhis,et al. Correlation of MDR1 gene expression with chemotherapy in neuroblastoma. , 1989, Journal of the National Cancer Institute.
[229] I. Pastan,et al. MDR1 gene expression in lung cancer. , 1989, Journal of the National Cancer Institute.
[230] H. Wieand,et al. Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors. , 1989, Cancer research.
[231] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[232] V. Ling,et al. Reduced permeability in CHO cells as a mechanism of resistance to colchicine , 1974, Journal of cellular physiology.
[233] I. Ieiri. Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2). , 2012, Drug metabolism and pharmacokinetics.
[234] Jin-jian Lu,et al. The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells , 2011, Molecular and Cellular Biochemistry.
[235] Maria-José U. Ferreira,et al. Inhibition of efflux pumps in methicillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina. , 2011, International journal of antimicrobial agents.
[236] A. di Pietro,et al. Selective modulation of P-glycoprotein activity by steroidal saponines from Paris polyphylla. , 2009, Fitoterapia.
[237] K. Kang,et al. Effect of resveratrol on the pharmacokinetics of oral and intravenous nicardipine in rats: possible role of P-glycoprotein inhibition by resveratrol. , 2009, Die Pharmazie.
[238] R. Aliya,et al. Seaweed as a new source of flavone, scutellarein 4'-methyl ether , 2009 .
[239] Jun-shik Choi,et al. Effects of oral kaempferol on the pharmacokinetics of tamoxifen and one of its metabolites, 4-hydroxytamoxifen, after oral administration of tamoxifen to rats. , 2008, Biopharmaceutics & drug disposition.
[240] J. Kulbacka,et al. Cytosolic superoxide dismutase activity after photodynamic therapy, intracellular distribution of Photofrin II and hypericin, and P-glycoprotein localization in human colon adenocarcinoma. , 2007, Folia histochemica et cytobiologica.
[241] M. Hennessy,et al. A primer on the mechanics of P-glycoprotein the multidrug transporter. , 2007, Pharmacological research.
[242] Maria-José U. Ferreira,et al. Apoptosis induction and modulation of P-glycoprotein mediated multidrug resistance by new macrocyclic lathyrane-type diterpenoids. , 2007, Bioorganic & medicinal chemistry.
[243] M. Totrov,et al. Waltzing transporters and 'the dance macabre' between humans and bacteria , 2007, Nature Reviews Drug Discovery.
[244] H. Kwon,et al. Isolation of limonoids and alkaloids fromPhellodendron amurense and their multidrug resistance (MDR) reversal activity , 2007, Archives of pharmacal research.
[245] Maria-José U. Ferreira,et al. Inhibition of multidrug resistance of cancer cells by natural diterpenes, triterpenes and carotenoids. , 2006, Current pharmaceutical design.
[246] S. Kimura,et al. Inhibition of leukemic cell growth by a novel anti‐cancer drug (GUT‐70) from calophyllum brasiliense that acts by induction of apoptosis , 2005, International journal of cancer.
[247] Edward J Kelly,et al. Characterization of the human MDR1 gene. , 2005, The AAPS journal.
[248] P. Limtrakul,et al. SCREENING OF FLAVONOIDS FOR THEIR POTENTIAL INHIBITORY EFFECT ON P-GLYCOPROTEIN ACTIVITY IN HUMAN CERVICAL CARCINOMA KB CELLS , 2004 .
[249] Ding Yan-fang. Reversal of adriamycin resistance by matrine in leukemia multidrug resistance cell line K562/ADM , 2004 .
[250] Zheng Shu. Cellular biological effects of matrine on K562 and K562/Vin cells , 2002 .
[251] M. Wink. Medicinal Natural Products. A Biosynthetic Approach , 2002 .
[252] L. Doyle,et al. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. , 2000, Cancer research.
[253] I. Pastan,et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. , 1999, Annual review of pharmacology and toxicology.
[254] A. Seelig. How does P-glycoprotein recognize its substrates? , 1998, International journal of clinical pharmacology and therapeutics.
[255] G. Barnett,et al. Induction of apoptosis in multi-drug resistant (MDR) human glioblastoma cells by SN-38, a metabolite of the camptothecin derivative CPT-11 , 1997, Cancer Chemotherapy and Pharmacology.
[256] P. Dewick,et al. Medicinal Natural Products: A Biosynthetic Approach , 1997 .
[257] C. Wilson,et al. Amplification of pfmdr 1 associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. , 1993, Molecular and biochemical parasitology.
[258] Y. C. Chen,et al. Expression of P-glycoprotein and glutathione-S-transferase in recurrent lymphomas: the possible role of Epstein-Barr virus, immunophenotypes, and other predisposing factors. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[259] M. Gottesman,et al. Is the multidrug transporter a flippase? , 1992, Trends in biochemical sciences.
[260] B. Sikic,et al. Multidrug Resistance ( mdr l ) Gene Expression in Adult Acute Leukemias : Correlations With Treatment Outcome and In Vitro Drug Sensitivity , 2003 .
[261] J. Gariépy,et al. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[262] M. Melamed,et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[263] M. Gottesman,et al. Multidrug resistance in the laboratory and clinic. , 1989, Cancer cells.